Last update 25 Jun 2026
Beijing Bio-Targeting Therapeutics Technology

Beijing Bio-Targeting Therapeutics Technology

Private Company | Subsidiary Company|2011|Beijing Shi, China

Overview

Tags

Neoplasms
Digestive System Disorders
Nervous System Diseases
Oncolytic virus

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Nervous System Diseases1
Neoplasms1
Top 5 Drug TypeCount
Oncolytic virus1
Top 5 TargetCount
IL-12R(Interleukin-12 receptor)1

Related

1
Drugs associated with Beijing Bio-Targeting Therapeutics Technology
Recombinant Human nsIL12 Oncolytic Adenovirus(VacV Biotheraputics)
Target
IL-12R
Mechanism
IL-12R stimulants
Active Org.
Beijing Bio-Targeting Therapeutics TechnologyBeijing Bio-Targeting Therapeutics Technology [+1]
Originator Org.
VacV Biotheraputics (UK) LtdVacV Biotheraputics (UK) Ltd
Active Indication
Metastatic Gastric Carcinoma [+13]
Inactive Indication
Locally advanced breast cancer
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
7
Clinical Trials associated with Beijing Bio-Targeting Therapeutics Technology
NCT07472790
/ Not yet recruitingPhase 1
A Single-arm Clinical Study on the Efficacy and Safety of the Novel Oncolytic Virus Ad-TD-nsIL12 Combined With PD-1 Inhibitor in the Treatment of Recurrent High-grade Glioma
NCT06283134
/ Not yet recruitingPhase 1IIT
A Clinical Study to Evaluate the Safety and Efficacy of Recombinant Human nsIL12 Oncolytic Adenovirus Injection (BioTTT001) in Combination With Toripalimab and Regorafenib in Patients With Liver Metastases From Colorectal Cancer
NCT07150767
/ WithdrawnPhase 1
A Clinical Study to Explore the Safety, Tolerability, and Efficacy of Recombinant Human nsIL12 Oncolytic Adenovirus Injection (BioTTT001) Combined With Neoadjuvant Treatment for Locally Advanced Breast Cancer
100 Clinical Results associated with Beijing Bio-Targeting Therapeutics Technology
Login to view more data
0 Patents (Medical) associated with Beijing Bio-Targeting Therapeutics Technology
Login to view more data
100 Deals associated with Beijing Bio-Targeting Therapeutics Technology
Login to view more data
100 Translational Medicine associated with Beijing Bio-Targeting Therapeutics Technology
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 01 Jul 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 2
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Recombinant Human nsIL12 Oncolytic Adenovirus(VacV Biotheraputics)
 ( IL-12R )		Advanced Malignant Solid Neoplasm
More
Phase 1
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free